Loading…
Cross Country Healthcare, Inc. is projected to rise to $15.14 by 2027, a +16% move from its current price of $13.07. CCRN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $12.82 | $13.08 | $13.34 | +0.06% |
| May 30 | $12.72 | $13.09 | $13.46 | +0.12% |
| May 31 | $12.65 | $13.09 | $13.55 | +0.19% |
| Jun 1 | $12.59 | $13.10 | $13.63 | +0.25% |
| Jun 2 | $12.54 | $13.11 | $13.71 | +0.31% |
| Jun 3 | $12.49 | $13.12 | $13.77 | +0.37% |
| Jun 4 | $12.45 | $13.13 | $13.84 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.45 | $13.13 | $13.84 | +0.43% |
| Week 2 | $12.24 | $13.18 | $14.20 | +0.87% |
| Week 3 | $12.09 | $13.24 | $14.51 | +1.30% |
| Week 4 | $11.97 | $13.30 | $14.78 | +1.74% |
| Week 5 | $11.87 | $13.35 | $15.03 | +2.18% |
| Week 6 | $11.79 | $13.41 | $15.26 | +2.62% |
| Week 7 | $11.72 | $13.47 | $15.49 | +3.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cross Country Healthcare, Inc. is a healthcare services company that provides talent management services for healthcare clients in the United States. It operates in two segments: Nurse and Allied Staffing, and Physician Staffing, offering traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurses and allied professionals, per diem, and long-term assignments, along with outsourcing and consultative services.
The company serves a broad range of healthcare providers, including hospitals, government facilities, managed care organizations, and other healthcare facilities. Cross Country Healthcare was founded in 1986 and is headquartered in Boca Raton, Florida.
Cross Country Healthcare, Inc. is currently priced at $13.05 with a market capitalization of $404.66M and a listed rank of 3216. The near-term outlook reflects bullish technical indicators alongside a robust price framework evidenced by recent price action.
A major floor 39.2% below — a decisive break under it would weaken the trend.
The nearest floor, 24.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.8% away) — a breakout level to watch.
A major ceiling 17.5% above — clearing it would confirm fresh momentum.
Key CCRN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CCRN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.07 | Sell | $13.07 | Buy |
| MA 10 | $13.09 | Sell | $12.91 | Buy |
| MA 20 | $12.26 | Buy | $12.35 | Buy |
| MA 50 | $10.70 | Buy | $11.17 | Buy |
| MA 100 | $9.78 | Buy | $10.61 | Buy |
| MA 200 | $10.80 | Buy | $11.00 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 75.93 | Sell |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 45.73 | Neutral |
| Williams %R (14) | -84.62 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -0.83 | Sell |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 15.38 | Buy |
| TRIX (15) | 1.11 | Buy |
| Awesome (5,34) | 1.78 | Buy |
| Ultimate (7,14,28) | 54.66 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 13.05 | Buy |
| ADX (14) | 41.47 | Buy |
| ATR (14) | 0.16 | Info |
The 30-day technical picture shows a range of $11.35 to $15.01, with a current bullish tilt supported by an RSI of 80 and prices above key moving averages (SMA50 is $10.55 and SMA200 is $10.80). There is a defined near-term support at $9.73 and resistance at $13.18, with volatility running around 40% annualized.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.95 | $13.07 | $17.84 | 0% | Neutral | |
| $12.32 | $15.14 | $19.50 | +16% | Neutral | |
| $13.82 | $17.31 | $22.92 | +32% | Bullish | |
| $15.85 | $20.17 | $27.28 | +54% | Bullish | |
| $17.78 | $22.95 | $31.61 | +76% | Bullish | |
| $21.31 | $27.85 | $39.00 | +113% | Bullish | |
| $23.08 | $30.53 | $43.38 | +134% | Bullish | |
| $23.60 | $31.56 | $45.44 | +141% | Bullish | |
| $25.80 | $34.87 | $50.83 | +167% | Bullish | |
| $25.84 | $35.28 | $52.02 | +170% | Bullish | |
| $41.90 | $59.83 | $92.61 | +358% | Bullish | |
| $77.18 | $118.78 | $197.58 | +809% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.95 | $13.07 | $15.28 | +0.00% |
| June 2026 | $11.32 | $13.22 | $15.74 | +1.13% |
| July 2026 | $11.77 | $13.83 | $16.63 | +4.60% |
| August 2026 | $11.98 | $14.14 | $17.13 | +2.24% |
| September 2026 | $11.88 | $14.08 | $17.17 | -0.42% |
| October 2026 | $12.04 | $14.32 | $17.57 | +1.75% |
| November 2026 | $12.26 | $14.63 | $18.03 | +2.13% |
| December 2026 | $12.04 | $14.40 | $17.84 | -1.54% |
Click any year to see its month-by-month CCRN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CCRN to range from $7.95 to $17.84 through 2026. The $13.07 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CCRN price prediction for 2027 points to an average of $15.14 (low $12.32, high $19.50) — a potential gain of +16% on today's $13.07. Price action looks broadly range-bound.
In 2028, CCRN is projected to trade between $13.82 and $22.92, averaging $17.31 — a potential gain of +32% from today's $13.07. That is up +14% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Cross Country Healthcare, Inc.'s 2029 outlook centres on $20.17, within a $15.85 to $27.28 range. That is up +16% on the projected 2028 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2030, CCRN could reach as high as $31.61, with a base case around $22.95 and support toward $17.78 — roughly +76% from $13.07. Buyers look set to stay in control over this stretch.
Expect CCRN to range from $21.31 to $39.00 through 2031. The $27.85 average target implies a +113% move from current prices. That is up +21% on the projected 2030 average. Momentum favours further upside here.
The CCRN price prediction for 2032 points to an average of $30.53 (low $23.08, high $43.38) — a potential gain of +134% on today's $13.07. Buyers look set to stay in control over this stretch.
In 2033, CCRN is projected to trade between $23.60 and $45.44, averaging $31.56 — a potential gain of +141% from today's $13.07. That is up +3% on the projected 2032 average. Momentum favours further upside here.
Cross Country Healthcare, Inc.'s 2034 outlook centres on $34.87, within a $25.80 to $50.83 range. That is up +10% on the projected 2033 average. That marks a +167% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CCRN could reach as high as $52.02, with a base case around $35.28 and support toward $25.84 — roughly +170% from $13.07. Momentum favours further upside here.
Expect CCRN to range from $41.90 to $92.61 through 2040. The $59.83 average target implies a +358% move from current prices. That is up +70% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CCRN price prediction for 2050 points to an average of $118.78 (low $77.18, high $197.58) — a potential gain of +809% on today's $13.07. Momentum favours further upside here.
Investing $1,000 in CCRN today (≈ 76.511094 CCRN) could be worth
$9,087.96
+$8,087.96 (+809%) by 2050 · US Dollar
Based on the average projected CCRN price of $118.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CCRNwould be worth at today's price.
$1,000 invested in CCRN on May 27, 2025 (≈ 73.909831 CCRN) would be worth
$966
-$34 (-3.4%) today · 0.97× · US Dollar
Based on a CCRN entry price of $13.53 vs. today's $13.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.11 | $996.95 | -0.3% |
| 1 month ago | $10.3 | $1,268.93 | +26.9% |
| 3 months ago | $8.77 | $1,490.31 | +49.0% |
| 6 months ago | $10.26 | $1,273.88 | +27.4% |
| 1 year ago | $13.53 | $966 | -3.4% |
| All time (5.0y) ago | $16.51 | $791.64 | -20.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CCRN forecast.
Our base-case forecast reaches $26.00 around 2031.
Implied market cap at $26.00: $806.21M
Forecasts project a rising price trajectory over the coming years. For 2026 the avg price is $13.05 with a min of $7.95 and a max of $17.96 (ROI 0; sentiment NEUTRAL). From 2027 onward, the averages and ROIs rise meaningfully: 2027 avg $15.51 (ROI 18.9), 2028 avg $17.92 (37.3), 2029 avg $21.06 (61.4), 2030 avg $24.40 (86.9), 2031 avg $29.65 (127.2), 2032 avg $32.60 (149.8), 2033 avg $34.04 (160.8), 2034 avg $37.72 (189.1), 2035 avg $38.37 (194).
The bullish trend continues with 2040 avg $66.61 (410.4) and 2050 avg $134.75 (932.6).
Tap a question to reveal the answer.
Avg $24.40, min $18.75, max $33.95; ROI 86.9; sentiment BULLISH.
The forecasts show rising avg prices through 2050 with substantial upside (e.g., 2040 ROI 410.4 and 2050 ROI 932.6). These are estimates, not guarantees.
2033 max is $49.62; 2034 max is $55.71, so it could reach and exceed $50 by 2034.
$11.35 to $15.01.
Cross Country Healthcare, Inc. Community Discussion
0Share your Cross Country Healthcare, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.